Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib and Temozolomide in Recurrent Glioblastoma
NCT01026493Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Jul 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in glioblastoma (GBM), Gliosarcoma (GS), sponsored by NRG Oncology. Started Jul 2010; status: completed.
02
Drugs
veliparib
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT01026493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026493.